BP-039Grade B26 supporting cases (24 counted), 0 counter-examples
Set a walk-away price from stand-alone value plus provable synergies, and re-test the deal when it changes
The practice
Before bidding, fix a walk-away price based on stand-alone value plus synergies you can prove, refuse to price off peak valuations or margins, and re-test the deal whenever its structure or diligence access changes.
Why it works
Auctions and contested bids create momentum: each round of bidding is anchored on the last, not on value. A walk-away price set beforehand, built from stand-alone value and only the synergies that can be evidenced, gives the board a fixed reference. Peak valuations of the acquirer's shares, peak margins and crisis-driven valuations all inflate what seems affordable. Limited diligence should lower the price, not be accepted as normal. When the structure of a deal changes during the contest, the original approval no longer applies. Comparing the deal with alternatives, such as the partnership it replaces, keeps the decision honest.
KB synthesis: the mechanism is the knowledgebase's own reasoning, drawn from the member lessons. Factual support is the case claims under evidence.cases and the research under evidence.research (R-refs).
How to apply it
- Set and minute a walk-away price before bidding, with the synergy evidence behind it.
- Value share-for-share deals on sustainable, not peak, valuations.
- Do not let peak margins or a crisis-driven valuation set long-term commitments.
- Quantify the synergies that justify a transformational merger before signing.
- Re-approve the deal if its structure, financing or diligence access changes.
Warning signs
- The price rises in rounds without a recorded re-approval.
- The financial case depends on current peak margins or share prices.
- Diligence access is restricted and the price is unchanged.
When it applies
- Auctions, contested bids, transformational mergers and capital commitments at cycle peaks.
When it does not
- Strategic options where the real value is defensive and cannot be priced; state that explicitly rather than inflating synergies.
Evidence grade: Grade B
At least 6 counted supporting cases for every 100 cases in the knowledgebase (6 × cases ÷ 100, rounded to the nearest whole number), whose primary regions span at least 4 regions.
Why this grade
Grade B by schema 4.10 route: >=14 counted cases across >=4 primary regions (the case bar is 6 per 100 cases in the knowledgebase, 235 cases). A needs a systematic, peer-reviewed study that tests this practice. None of the research cited in the KB does. 2 supporting case(s) rest only on company-reported claims and are not counted toward the grade.
Where it applies
- Transformation type
- Topic (business problem)
- Function
- Starting situation
- Industry
- Region
Supporting and counter cases
Tata Steel CS-082
The Kraft Heinz Company CS-050
Magazine Luiza S.A. (Magalu) CS-022
Schneider Electric SE CS-098
The Walt Disney Company CS-032
Haggen, Inc. (Haggen Food & Pharmacy), owned by the private-equity firm Comvest CS-101
Dewey & LeBoeuf LLP CS-108
Slater and Gordon Limited CS-109
Avianca Holdings S.A., reorganised as Avianca Group International Limited CS-126
Grupo Bimbo, S.A.B. de C.V. (US subsidiary Bimbo Bakeries USA) CS-130
Teva Pharmaceutical Industries Ltd. (listed in New York and Tel Aviv, headquartered in Israel) CS-138
Ciech S.A. (CIECH Group), Polish chemicals group listed on the Warsaw Stock Exchange CS-142
Researched and fact-checked knowledgebase · Knowledgebase built 5 November 2026
Practices, their evidence grades and case summaries are public. Full case studies are available in AXIOM to subscribers and AXIOM Discover participants.

